UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Blog
4 min read

Achieving Global Harmonization: PV & RMP Regulatory Compliance

UBC Pharmacovigilance experts, Helena Pedrosa and Philippe Botteron presented at DIA Europe on how to achieve global harmonization of PV

Posts by Date

Blog
4 min read

Achieving Global Harmonization: PV & RMP Regulatory Compliance

UBC Pharmacovigilance experts, Helena Pedrosa and Philippe Botteron presented at DIA Europe on how to achieve global harmonization of PV & RMP regulatory compliance.
Blog
4 min read

UBC Participates in Rare Disease Day® at NIH 2024

UBC joined patients, researchers, and industry leaders at this year’s Rare Disease Day at NIH to discuss advancing research, improving diagnostics, and accelerating treatments for those living with rare diseases.
Blog
4 min read

The Joint Clinical Assessment Affect on European Patient Access

Find out what the new Joint Clinical Assessment from the European Union could mean for accelerating patient access to innovative medicines.
Blog
7 min read

Pharmacovigilance AI Best Practices: How to Apply the EU AI Act 2023

Read into the latest PV AI Best Practices, discover how to apply the EU AI Act 2023.
Blog
1 min read

Podcast: Considerations for How AI Will Impact Your Brand’s Patient Services

UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
Blog
3 min read

FDA Finalizes Guidance On Registries’ Contributions to Regulatory Submissions

Read into the implications of the latest guidance from the FDA on registries usefulness for various purposes and how to best build one.
Blog
6 min read

How to Introduce AI-Powered Analytics to Patient Services

Utilizing AI-powered analytics for your patient services data can help unlock benefits that ultimately improve patient outcomes.
Blog
7 min read

Real-World Evidence Opportunities for Emerging Biotech

The use of real-world evidence has greatly expanded in recent years but is still underutilized by emerging biotechs.
Blog
4 min read

KAB Surveys: Establishing a Threshold of Demonstrated Understanding

Learn more about how to utilize Knowledge, Attitude, and Behavior Surveys to evaluate stakeholders in your REMS program.
1 2 3 13

Press Inquires

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.